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Sorting ofSphingolipids in the Endocytic Pathway of HT29 Cells
Jan Willem Kok, Teresa Babia, and Dick Hoekstra
University ofGroningen, Laboratory ofPhysiological Chemistry, Bloemsingel 10, 9712 KZ Groningen, The Netherlands
Abstract. The intracellular flow and fate of two
fluorescently labeled sphingolipids, 6-[N-(7-nitro-2,1,3-
benzoxadiazol-4-yl)amino]hexanoyl glucosyl sphingo-
sine (C6-NBD-glucosylceramide) and C6-NBD-
sphingomyelin, was examined in the human colon ade-
nocarcinoma cell line HT29. After their insertion into
the plasma membrane at low temperature and subse-
quent warming of the cells to 37°C, both sphingolipid
analogues were internalized by endocytosis, but their
intracellular site of destination differed . After 30 min
of internalization, C6-NBD-glucosylceramide was
localized in the Golgi apparatus, as demonstrated by
colocalization with fluorescently labeled ceramide, a
Golgi complex marker, and by showing that monensin-
induced disruption of the Golgi structure was paral-
leled by a similar perturbation of the fluorescence dis-
tribution . By contrast, C6-NBD-sphingomyelin does
SORTING and recycling are well-known phenomena in in-tracellular protein trafficking, occurring during bio-synthesis and endocytosis (1, 11, 13) . The importance
of these kind of processes in the concomitant intracellular
flow of lipids is now also gradually emerging . Several sphin-
golipids have been shown to reappear at the plasma mem-
brane by a recycling mechanism, after exogenous membrane
insertion and subsequent internalization via the endocytic
pathway (5, 6) . In polarized cells, sorting of two newly syn-
thesized sphingolipids, derived from a common precursor,
has been shown to occur, as reflected by lipid specific, out-
bound trafficking to apical, and basolateral membrane do-
mains (14) . However, it remains to be resolved whether
lipids are also subject to sorting during inbound cellular
trafficking, i .e., in endocytic events .
During endocytosis, an extensive flow ofmembranes takes
place . To monitor the trafficking pathways of lipids during
this process, advantage can be taken of the intracellular pro-
cessing of certain ligand-receptor complexes . This process-
ing involves delivery to endosomal compartments, sorting,
and either recycling to the plasma membrane or further
movement down the endocytic pathway towards the lyso-
somal system (1, 12) .
In the present study, it is shown that two fluorescently la-
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not colocalize with the tagged ceramide. Rather, a
colocalization with ricin, which is internalized by en-
docytosis and predominantly reaches the lysosomes,
was observed, indicating that the site of delivery of
this lipid is restricted to endosomal/lysosomal com-
partments . Also, in monensin-treated cells no change
in the distribution of fluorescence was observed . Thus,
these results demonstrate that (sphingo)lipid sorting
can occur in the endocytic pathway. Interestingly, the
observed sorting phenomenon was specific for
glucosylceramide, when compared to other glyco-
lipids, while only undifferentiated HT29 cells dis-
played the different routing of the two lipids . In
differentiated HT29 cells the internalization pathway of
sphingomyelin and glucosylceramide was indistinguish-
able from that of transferrin .
beled sphingolipids, C6-NBD-glucosylceramide and C6-
NBD-sphingomyelin, are sorted during internalization along
the endocytic pathway in HT29 cells . Using transferrin
(Tf)l and ricin (in conjunction with their receptors) as in-
tracellular traffic markers, evidence is presented indicating
that C6-NBD-glucosylceramide is transported to the Golgi
apparatus, whereas C6-NBD-sphingomyelin follows the en-
docytic pathway, down to the endosomal/lysosomal system .
Furthermore, when the trafficking ofthese sphingolipids was
compared in an undifferentiated and a differentiated HT29
cell type, the latter being derived by clonal selection, it could
be shown that this sorting phenomenon only occurred in the
undifferentiated cell type . This distinct difference between
the two cell types may imply that lipid transport routes and
sorting phenomena are related to differentiation of cells .
Materials and Methods
Materials
1-ß-D-glucosylsphingosine, cerebroside type II, N-palmitoyl-DL-dihydro-
lactocerebroside, sphingosylphosphorylcholine, D-sphingosine, iron-free
Tf, and monensin were purchased from Sigma Chemical Co. (St . Louis,
MO) . 6-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoic acid and lis-
1 . Abbreviations used in thispaper: DECA, [[[7-(diethylamino)coumarin-3-
yl]carbonyl]methylamino] ; LR, lissamine rhodamine B sulfonylchloride ;
Tf, transferrin .
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Figure 1. Intracellular localization of sphingolipids in undifferentiated HT29 cells . Cells were labeled with 4 UM C6-NBD-
glucosylceramide (a and c), C6-NBD-galactosylceramide (e), or C6-NBD-sphingomyelin (g and i), as described in Materials and
Methods. Internalization was allowed to proceed for 30 min at 37°C, followed by a back-exchange procedure at 2°C. Colabeling studies
were performed with either DECA-ceramide (b and h) or LR-ricin (d, f, and j) as described in Materials and Methods. Note that C6-
NBD-glucosylceramide colocalizes with DECA-ceramide (a and b), but not with LR-ricin (c and d) . C6-NBD-sphingomyelin colocalizes
with LR-ricin (i and j), but not with DECA-ceramide (g and h) . Bars, 10 um .




samine rhodamine B sulfonylchloride (LR), 10% (wt/wt) on celite, were
fromMolecular Probes Inc . (Eugene, OR) . [[[7-(diethylamino)coumarin-3-
yl] carbonyl]methylamino]-ceramide was a gift from Dr. G. van Meer
(University of Utrecht, The Netherlands) and ricin RCA60 was a gift from
Dr. E. Nicolas (Université René Descartes, Paris, France) .
Synthesis ofC6-NBD-labeled Sphingolipids
C6-NBD-glucosylceramide, C6-NBD-galactosylceramide, C6-NBD-lacto-
sylceramide, C6-NBD-sphingomyelin, and C6-NBD-ceramide were synthe-
sized from C6-NBD and 1o-D-glucosylsphingosine, 1-ß-D-galactosylsphin-
gosine, 1-ß-DL-lactosyldihydrosphingosine, sphingosylphosphorylcholine,
and D-sphingosine, respectively, as described (4) . 1-ß-D-galactosylsphingo-
sine and 1-ß-13L-lactosyldihydrosphingosine were prepared (3) from cerebro-
side (type II) and N-pahnitcyl-DL-dihydrolactocerebroside, respectively.
The C6-NBD-lipids were quantitated spectrophotometrically in a fluo-
rometer (model MPF-43 ; Perkin-Elmer Corp., Norwalk, CT) with an exci-
tation wavelength of465 nm and an emission wavelength of530 nm, by ref-
erence to known amounts of C6-NBD-phosphatidylcholine.
Protein Labeling
Saturation of Tf with iron was carried out by the procedure of Van Rens-
woude et al . (15) . Diferric Tf and ricin were conjugated with LR as de-
scribed elsewhere (5) .
Cell Culture andMembrane Insertion of
Fluorescent Lipids
Monolayer cultures of HT29 cells were grown in DME, supplemented with
10% (vol/vol) FCS in a water-saturated atmosphere of 5% COZ/95% air.
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Experiments were carried out 24-48 h after passage . C6-NBD-lipid inser-
tion was carried out at 2°C . Before labeling, the cells were cooled to 2°C
(30 min) . Appropriate amounts of C6-NBD-lipid, stored in chloro-
form/methanol (2 :1 [vol/vol]), were dried under nitrogen, and subsequently
solubilized in absolute ethanol . An aliquot of the ethanolic solution (0.5%
final concentration) was injected into Hank's solution (pH 7.4) undervigor-
ous vortex mixing . This solution was then added to the cells . Alternatively,
several microscopy experiments were carried out using C6-NBD-lipid con-
taining liposomes for labeling, as described elsewhere (5) . Both procedures
used for labeling yielded identical results .
Back-Exchangefor Membrane-inserted
Lipid Analogues
Back-exchange was carried out by incubating the cells for 30 min at 2°C
with 5% (wt/vol) BSA in Hank's solution, followed by extensive washing
with Hank's solution. This procedure was repeated twice .
Metabolic Studies
Procedures used for carrying out metabolic studies were analogous to those
described below for the microscopy experiments, allowing direct correla-
tion of the results . After the 37°C incubation (and extensive washing), a
back-exchange procedure was carried out at 2°C, in order to separate the
plasma membrane NBD-lipid fraction from the intracellular pool . Both
fractions were analyzed as described below.
Lipid Extraction, Analysis, and Quantification
Lipids were extracted by the procedure of Bligh and Dyer and analyzed by
two-dimensional TLC on silica gel 60 HPTLC plates (Merck & Co ., Rah-
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way, NJ), using CHC13/CH30H/20% (wt/vol) NH40H [70 :30 :5] as the
running solvent system in the first dimension and CHC13/CH30H/86%
(vol/vol) HAc [90:40 :14] in the second dimension, allowing separation of
five different C6-NBD-lipid spots associated with HT29 cells . To positively
identify C6-NBD-galactosylceramide as one of the C6-NBD-lipids synthe-
sized fromC6-NBD-ceramide in HT29 cells, the TLC-system as described
by Van Meer et al . (14) was employed . For quantification, individual spots
were scraped from the plates and after addition of 3 ml of a 1% (vol/vol)
Triton X-100 solution, shaken vigorously for 1 h at 37°C. After spinning
down the silica particles, the supernatant was measured by reference to a
standard curve, as described above. Corrections were made for differences
in efficiency of removal of different types of lipids from the silica. Data are
expressed as the means (t SEM) of triplicate measurements .
Microscopy
Cells were grown on glass coverslips in 35-mm Petri dishes. Before experi-
ments, the cells were cooled (30 min) and washed several times with ice-
cold Hank's solution. For colabeling studies with fluorescently labeled ncm,
the cells were labeled with LR-ricin (15 pg/ml) for 30 min at 2°C . Internali-
zation of membrane-bound ricin (after washing away free ricin) was initi-
ated by adding warm Hank's solution (37°C) and allowed to proceed for 60
min . Thereafter, the cells were again cooled to 2°C, followed by labeling
with the C6-NBD-lipid for 30 min at 2°C . After washing, internalization
was started again by adding warm Hank's solution and terminated after 30
min by replacing warm buffer with ice-cold one . Finally, a back-exchange
procedure was done at 2°C, followed by a 0.1 M lactose wash (30 min at
2°C) to remove cell surface-bound ricin .
For colabeling studies with fluorescently labeled Tf, the cells were first
labeled with the C6-NBD-lipid for 30 min at 2°C, followed by washing
with Hank's solution and subsequent labeling with LR-Tf(0.2 mg/ml) . Inter-
nalization was allowed to proceed for 30 min, after which a back-exchange
procedure was performed at 2°C . Colabeling studies with DECA-ceramide
were done as described above for LR-Tf, except that the cells were first la-
beled with DECA-ceramide (1 AM), as described for the C6-NBD-lipids,
followed by labeling with the C6-NBD-lipid . The labeling concentration of
the C6-NBD-lipids was 4 AM .
Monensin experiments were performed by preincubating the cells with
the drug (10- s M) for 30 min at 2°C . Thereafter, the cells were labeled
with the C6-NBD-lipid followed by internalization and back-exchange .
Throughout these experimental treatments the drug waspresent. Metabolic
inhibition experiments were performed asdescribed (10) . Briefly, cells were
preincubated at room temperature for 5 min with 5 mM azide/50 MM
2-deoxyglucose, followed by NBD-sphingolipid labeling at 2°C and subse-
quent warming of the cells to 37°C in the presence of the drugs. Acidifica-
tion of the cytosol was achieved by incubating the cells for 30 min at 2°C
with 5 AM nigericin in an isotonicKCl buffer solution (140 mM KC1, 2 mM
CaC12, 1 rr1M MgC12, 0.5 MM KH2PO4, 20 mM Hepes, pH 5.5) . All sub-
sequent washings and incubations were carried out with the same nigericin-
containing buffer solution . After experimental manipulation, the glass cov-
erslips were removed from the Petri dishes and mounted for microscopy.
Fluorescence microscopy was performed with a Leitz Orthoplan micro-
scope equipped with a Leitz VarioOrthomat 2 photography system, and the
following filter sets: purple excitation, BP 340-410/LP 470 (DECA
channel) ; blue excitation, BP 450-490/LP 515 (NBD-channel) ; and green
excitation, BP 530-560/LP 580 (Rh-channel) . Photomicrographs were
taken at 10-30-s exposure times using Kodak Tmax P3200 film that was
processed at 12 .800 ASA .
Resultsand Discussion
C6-NW-Sphingolipid Metabolism in H729 Cells
When HT29 cells are incubated with C6-NBD-ceramide,
either at 2°C or 37°C, the lipid is taken up into the cells and
at 37°C accumulates in the Golgi apparatus where several
NBD-sphingohpids are synthesized . Similar observations
have been described for other cell types (7, 14) . The two
main lipid products synthesized are C6-NBD-glucosylcera-
mide and C6-NBD-sphingomyelin . However, the cells also
synthesize C 6-NBD-galactosylceramide, C6-NBD-lactosyl-
ceramide, and a third, as yet unidentified C6-NBD-sphingo-
lipid (Babia, T., J. W Kok, and D. Hoekstra, manuscript in
preparation) .
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C6-NW-Sphingolipid Internalization
C6-NBD-glucosylceramide and C6-NBD-sphingomyelin can
be inserted into the plasma membrane of HT29 cells at 2°C
with the ethanol-injection procedure . Under these conditions
both lipids only label the plasma membrane and, in contrast
to their precursor C6-NBD-ceramide, do not gain access to
intracellular membranes. However, when the cells are warmed
to 37°C the lipids are internalized, but their intracellular
sites of destination are different .
As shown in Fig . 1, C6-NBD-glucosylceramide is trans-
ported to the Golgi apparatus. It colocalizes with DECA-
ceramide, a fluorescent derivative of ceramide, which, like
the C6-NBD-derivative, can be used as a vital stain for the
Golgi apparatus (Fig . 2 ; Ref. 8) . Because of its distinct
fluorescent properties, DECAceramide is a convenient
probe for double-labeling studies with NBD-labeled lipids .
Further support for the Golgi localization of C6-NBD-
glucosylceramide comes from experiments in which monen-
sin was used as a reagent that can disrupt the structural orga-
nization ofthe Golgi complex . As a resultofsuch a treatment
(Fig. 2), the Golgi complex in HT29 cells, normally visual-
ized as large, irregularly shaped vesicles that are distinctly
located around the nucleus, becomes vesiculated and more
spread over the cell . As shown in Fig . 2, in comparison to
its distribution in nontreated cells (Fig . 1), the distribution
of C6-NBD-glucosylceramide is similarly disrupted in the
presence of monensin.
In contrast to C6-NBD-glucosylceramide, internalized
C6-NBD-sphingomyelin did not colocalize with DECA-
ceramide, implying that sphingomyelin is not transported to
the Golgi apparatus. Instead, it was found in an intracellular
compartment that can be labeled by LRricin which is taken
up into the cells by endocytosis . This result thus indicates
that this lipid is transported and confined to the en-
dosomal/lysosomal system . Entirely consistent with this no-
tion was the observation that the labeling pattern of NBD-
sphingomyelin was not changed after a treatment with
monensin that causes disruption of the Golgi (Fig. 2) .
Back-exchange experiments revealed that after 30 min at
37°C -10-15% of the initial membrane-inserted lipid frac-
tion is located intracellularly. The internalization of both
lipids is temperature dependent and can be inhibited in the
presence of metabolic inhibitors (5 mM azide/50 mM 2-de-
oxyglucose) (Fig . 3) or when the intracellular pH is lowered
to 5.5 with the aid of nigericin (not shown) . Therefore, inter-
nalization is energy dependent and accomplishedby endocy-
tosis (2, 10) . It is highly relevant to note here that on the time
scale of the experiments no appreciable breakdown of the
C6-NBD-sphingolipids had taken place, as revealed by lipid
analyses . The relevance of this notion stems from the fact
that the observed labeling ofthe Golgi complex by glucosyl-
ceramide might (in part) have been the result of initial
lysosomal degradation of glucosylceramide to ceramide, fol-
lowed by transfer and accumulation ofthis degradation prod-
uct in the Golgi compartment (8, 9) . The ceramide, in turn,
could then have been reutilized (6, 9) for synthesis of glu-
cosylceramide (and sphingomyelin, see below) . However,
this possibility can be ruled out . Analysis ofthe intracellular
pool of NBD-lipid revealed that after an incubation period of
30 min at 37°C, 91.3 % (t 1.4%) ofthe intracellular fraction
was still present as C6-NBD-glucosylceramide . Further-
more, 6.9% (t 0.9%) was identified as C6-NBD-ceramide,
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Figure 2. Effect of monensin on NBD-sphingolipid fluorescence distribution . (a and b) Cells were first labeled with DECA-ceramide (1
AM), followed by labeling with NBD-ceramide (4 AM) . Thereafter, the cells were incubated at 37°C for 30 min. Both NBD-ceramide
(a) and DECA-ceramide (b) accumulate in the Golgi-apparatus and thus show the same fluorescence distribution . (c-e) Cells were labeled
with 4 AM C6-NBD-ceramide (c), C6-NBD glucosylceramide (d), or C6-NBD-sphingomyelin (e) as described in Materials and Methods.
Subsequently, the cells were preincubated for 30 min at 2°C with 10 AM monensin, followed by an incubation at 37°C for 30 min in the
presence of the drug. Finally, a back-exchange procedure was carried out. Note the similarity in fluorescence distribution between NBD-
ceramide (c) and NBD-glucosylceramide (d) in monensin-treated cells, and the difference with control cells (a and Fig. 1, a and c, respec-
tively) . There is no effect on NBD-sphingomyelin fluorescence distribution (e compared to Fig. 1, g and t) . Bar, 10 Am .
Kok et al . Sphingolipid Sorting in the Endocytic Pathway
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Figure 3. Inhibition of internalization by metabolic inhibitors . Cells were preincubated for 5 min at room temperature with metabolic inhibi-
tors (5 mM azide/50 mM 2-deoxyglucose) . Thereafter the cells were labeled with 4 pM C6-NBD-glucosylceramide (a and b) or C6-NBD-
sphingomyelin (c and d), followed by an incubation at 37°C for 30 min in the presence ofthe inhibitors . Finally, aback-exchange procedure
was carried out . b and d show the corresponding phase-contrast images. Bar, 10 Am .
whereas only 1.9% (t 1.1%) of the intracellular NBD-lipid
fraction has been reused for synthesis to C6-NBD-sphingo-
myelin . It should also be noted that the lipid present in the
plasma membrane consisted exclusively (99.6 t 0.3%) of
C6-NBD-glucosylceramide (as determined by analysis of
the back-exchanged lipid fraction) . When the sphingolipid
precursor, C6-NBD-ceramide, was supplied to the cells for
a similar incubation period (30 min at 37°C), both gluco-
sylceramide and sphingomyelin were synthesized (as noted
above), while the ratio of glucosylceramide to sphingomye-
lin in which they were produced is 1 .3 (t 0.1) .
Taken together, it can thus be calculated that only 2.5
of the intracellular glucosylceramide fraction (which
amounts to 91.3%) can at most have been derived from
degradation and resynthesis. These considerations imply,
therefore, that the fate of the original and intact C6-NBD-
glucosylceramide is monitored, as it is transported from the
plasma membrane to the Golgi complex . It thus follows that
C6-NBD-glucosylceramide and C6-NBD-sphingomyelin are
actively sorted in HT29 cells during endocytic uptake .
Whether early endosomes play a pivotal role in this lipid
The Joumal of Cell Biology, Volume 114, 1991
sorting event-analogous to events in ligand/receptor
trafficking-remains to be established . In this context it is in-
teresting to note, however, that the sorting process as such
seems to be rather specific . This became apparent when the
trafficking of C6-NBD-glucosylceramide was compared to
that of the closely related sphingolipids C6-NBD-galacto-
sylceramide and C6-NBD-lactosylceramide, both of which
can be synthesized by the HT29 cells (see above) . Of these
three glycolipids, only C6-NBD-glucosylceramide is trans-
ported to the Golgi apparatus . Both C6-NBD-galactosylcer-
amide and C6-NBD-lactosylceramide, similarly as observed
for C6-NBD-sphingomyelin, were processed along the endo-
somal/lysosomal route (Fig . 1) .
Interestingly, when the trafficking of C6-NBD-glucosyl-
ceramide and C6-NBD-sphingomyelin, occurring in undif-
ferentiated HT29 cells, was compared to that in a differen-
tiated type of HT29 cells (isolated by clonal selection ; Babia,
T., J . W Kok, and D. Hoekstra, manuscript in preparation),
sorting between the lipids no longer occurred . As shown in
Fig . 4, in differentiated cells both C6-NBD-sphingolipids
followed the endocytic pathway during internalization and
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Figure 4. Intracellular localization of sphingolipids in differentiated HT29 cells . Cells were labeled with 4 uM C6-NBD-glucosylceramide
(a, e, and i) or C6-NBD-sphingomyelin (c and g), as described in Materials and Methods. Internalization was allowed to proceed for 30
min at 37°C, followed by a back-exchange procedure at 2°C. Colabeling studies were performed with LRTf (b and d), LR-ricin (fand
h), or DECA-ceramide (j), as described in Materials and Methods. Both C6-NBD-glucosylceramide and C6-NBD-sphingomyelin colocal-
ize with both LRTf and LR-ricin . Note that C6-NBD-glucosylceramide does not colocalize with DECA-ceramide (i and j), as opposed
to their colocalization in undifferentiated HT29 cells (Fig . 1, a and b) . Bar, 10 pm .




perfectly colocalized with rhodamine-labeled Tf, a well-known
marker for receptor-mediated endocytosis (15) . Colocaliza-
tion was also observed in double-labeling studies with LR-
ricin as the endocytic marker. In this case, however, both
sphingolipids and ricin were often found to colocalize in
bright juxtanuclear patches of fluorescence (Fig . 4) . This
typical distribution pattern of endocytic vesicles may have
been induced by the ricin, since no such patches were ob-
served in double-labeling studies with Tf. In contrast to its
localization in undifferentiated HT29 cells (Fig. 1 ; see above),
C6-NBD-glucosylceramide does not colocalize with DECA-
ceramide in this cell type, because the lipid is nottransported
to the Golgi apparatus (Fig. 4) .
In summary, the results show that two C6-NBD-
sphingolipids, glucosylceramide and sphingomyelin, are ac-
tively sorted during endocytosis in undifferentiated HT29
cells . This sorting process is lipid specific, since out of sev-
eral glycolipids only C6-NBD-glucosylceramide is sorted
from C6-NBD-sphingomyelin . Furthermore, this phenome-
non appears to be related to the state ofdifferentiation of the
cells, being a property of the undifferentiated cells only.
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